In 2004, Sharon was diagnosed with stage 4 melanoma when she was just 22 years old. She started chemotherapy a few days before her wedding and experienced horrific side effects including neuropathy. She then switched to interleukin-2, which did not work and irritated her skin. Her oncologist, Dr. Jedd Wolchok at Memorial Sloan Kettering Cancer Center, told her about a new type of treatment called ipilimumab (Yervoy®) that “takes the brakes off” the immune system. She almost immediately agreed to enroll in the study. After only a few rounds of treatment, scans revealed that her tumors had shrunk by 60 percent. She has been in remission since. She is now a personal trainer and fitness instructor striving to help others on their health and fitness journeys, as well as a CRI ImmunoAdvocate spreading the word about immunotherapy.